132 results
Page 5 of 7
F-1
4m6nihfveb3pgx7sn8
8 Sep 22
Registration statement (foreign)
1:02pm
6-K
EX-99.1
v2bupzb295vdj
1 Sep 22
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2022
8:10am
6-K
EX-99.1
2j366kr1ivii3rlyl
22 Aug 22
XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study
7:46am
DRS
amsjknrnwop2cf
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
3208aie 9l
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.1
uzw5o7becdc5
4 Aug 22
XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
7:00am
6-K
EX-99.1
3ou6asm7mrlz
22 Jul 22
XORTX Reports Annual & Special Meeting Results
8:00am
6-K
EX-99.1
nll gxvq3316m
19 Jul 22
XORTX Announces Submission to European Medicines Agency
7:00am
6-K
EX-99.1
pn6 a4ccdkcu3z2w
14 Jul 22
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
11:03am
6-K
EX-99.1
rtjnfyeiznq3gg lstb
7 Jul 22
Current report (foreign)
7:00am
6-K
EX-99.2
3vzr5q24skv3zayg9n
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
6-K
EX-99.1
gvdullyjtkf1zafiv5dw
29 Jun 22
Current report (foreign)
9:58pm
6-K
EX-99.1
34vno wm6zho
21 Jun 22
XORTX Announces “Fireside Chat” with XORTX CEO
7:52pm
6-K
EX-99.1
92qff cg1l
13 Jun 22
XORTX to Present at BIO International Convention 2022
9:26am
6-K
EX-99.1
dbn ky7cs
8 Jun 22
XORTX to Present at LD Micro Invitational 2022
7:00am
6-K
EX-99.1
qvd1fg8vpz6kgmiv
6 Jun 22
XORTX Welcomes New Member to the Board of Directors and Appoints Chair
7:00am
6-K
EX-99.1
ttlt7zoudeevpyucq1
25 May 22
XORTX to Present at H. C. Wainwright Global Investment Conference 2022
8:00am
6-K
EX-99.2
ex48ctkjwvjsf
16 May 22
Condensed Interim Consolidated Financial Statements
7:25am
6-K
EX-99.1
1eryt4w 2p1y424t
5 May 22
Current report (foreign)
7:00am
20-F
EX-15.1
r0rmfw
3 May 22
Annual report (foreign)
5:29pm